Position in GRAL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,747,506
-$1,450,905 QoQ
Shares Held
33,814
-9.5% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 83.65469923700243.ToString("F0")%
Shared 0.ToString("F0")%
None 16.345300762997574.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026STIFEL FINANCIAL CORP holds $672,124,718 across 23 Diagnostics & Research names. GRAL ranks #15 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
649,147 | $319,075,223 | |
| 2 | DHR |
Danaher Corp /De/
|
725,614 | $137,576,412 | |
| 3 | ILMN |
Illumina, Inc.
|
475,251 | $58,579,436 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
154,592 | $26,364,118 | |
| 5 | LH |
Labcorp Holdings Inc.
|
93,060 | $24,829,336 | |
| 6 | DGX |
Quest Diagnostics Inc
|
112,033 | $21,956,225 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
35,765 | $20,095,993 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
38,477 | $18,476,270 |
All Filings in GRAL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,747,506 | 33,814 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,198,411 | 37,369 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,854,262 | 48,271 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,773,783 | 34,496 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $803,895 | 31,476 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $624,605 | 34,992 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $406,056 | 29,510 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||